Holdings of Tema Heart & Health ETF
Tema ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 51.9M $ including 51.5M $ in equities, 99.2 %
- Positions
- 44 in 7 countries
- Top ten
- 49.1 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 5,413 | 6M $ | 11.52 % |
| 2 | UnitedHealth Group Inc | 7,159 | 2.7M $ | 5.24 % |
| 3 | Novo Nordisk A/S | 59,455 | 2.7M $ | 5.24 % |
| 4 | Roche Holding AG | 44,538 | 2.3M $ | 4.50 % |
| 5 | Merck & Co Inc | 18,672 | 2.2M $ | 4.27 % |
| 6 | AstraZeneca PLC | 11,178 | 2.1M $ | 4.00 % |
| 7 | Thermo Fisher Scientific Inc | 4,185 | 2.1M $ | 3.97 % |
| 8 | Johnson & Johnson | 8,274 | 1.9M $ | 3.59 % |
| 9 | Gilead Sciences Inc | 13,261 | 1.8M $ | 3.43 % |
| 10 | Novartis AG | 11,627 | 1.8M $ | 3.38 % |
| 11 | REVOLUTION MEDICINES INC | 10,971 | 1.7M $ | 3.33 % |
| 12 | Vertex Pharmaceuticals Inc | 3,398 | 1.5M $ | 2.93 % |
| 13 | Danaher Corp | 7,557 | 1.4M $ | 2.66 % |
| 14 | Abbott Laboratories | 15,809 | 1.4M $ | 2.61 % |
| 15 | Bridgebio Pharma Inc | 20,327 | 1.3M $ | 2.59 % |
| 16 | CYTOKINETICS INC | 17,069 | 1.3M $ | 2.52 % |
| 17 | AbbVie Inc | 5,714 | 1.2M $ | 2.40 % |
| 18 | Bristol-Myers Squibb Co | 18,939 | 1.1M $ | 2.09 % |
| 19 | Teva Pharmaceutical Industries Ltd | 30,273 | 1.1M $ | 2.06 % |
| 20 | Dexcom Inc | 13,512 | 996.4K $ | 1.92 % |
| 21 | Amgen Inc | 2,946 | 992.2K $ | 1.91 % |
| 22 | Medtronic PLC | 13,203 | 974.5K $ | 1.88 % |
| 23 | Edwards Lifesciences Corp | 10,488 | 906.9K $ | 1.75 % |
| 24 | McKesson Corp | 1,196 | 888K $ | 1.71 % |
| 25 | Regeneron Pharmaceuticals Inc | 1,408 | 865.6K $ | 1.67 % |
| 26 | Madrigal Pharmaceuticals Inc | 1,519 | 755.4K $ | 1.46 % |
| 27 | Boston Scientific Corp | 15,285 | 738.4K $ | 1.42 % |
| 28 | Chugai Pharmaceutical Co Ltd | 13,915 | 689.5K $ | 1.33 % |
| 29 | Intuitive Surgical Inc | 1,590 | 675.2K $ | 1.30 % |
| 30 | ALNYLAM PHARMACEUTICALS INC | 1,954 | 590.1K $ | 1.14 % |
| 31 | Arrowhead Pharmaceuticals Inc | 7,240 | 564.1K $ | 1.09 % |
| 32 | Scholar Rock Holding Corp | 9,647 | 475.6K $ | 0.92 % |
| 33 | Xenon Pharmaceuticals Inc | 8,393 | 459.3K $ | 0.88 % |
| 34 | IONIS PHARMACEUTICALS INC | 5,599 | 428.3K $ | 0.83 % |
| 35 | Insulet Corp | 2,835 | 410.9K $ | 0.79 % |
| 36 | Ascendis Pharma A/S | 1,755 | 393.3K $ | 0.76 % |
| 37 | Insmed Inc | 3,449 | 368.7K $ | 0.71 % |
| 38 | Stoke Therapeutics Inc | 10,049 | 310.6K $ | 0.60 % |
| 39 | Viking Therapeutics Inc | 8,538 | 279.5K $ | 0.54 % |
| 40 | MBX BIOSCIENCES INC | 8,761 | 275.7K $ | 0.53 % |
| 41 | Zealand Pharma A/S | 5,293 | 268.4K $ | 0.52 % |
| 42 | Gubra A/S | 4,487 | 250.3K $ | 0.48 % |
| 43 | Intellia Therapeutics Inc | 13,892 | 195.5K $ | 0.38 % |
| 44 | STRUCTURE THERAPEUTICS INC | 4,583 | 180.3K $ | 0.35 % |
Sector breakdown
- Health care 78.7 %
- Unattributed 21.3 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 84.9 %
- DKK 6.3 %
- GBP 4.0 %
- CHF 3.4 %
- JPY 1.3 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 76.7 %
- Switzerland 7.9 %
- Denmark 7.1 %
- United Kingdom 4.0 %
- Israel 2.1 %
- Japan 1.3 %
- Canada 0.9 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 34 | 39.5M $ | 76.66 % |
| 2 | Switzerland | 2 | 4.1M $ | 7.94 % |
| 3 | Denmark | 4 | 3.6M $ | 7.05 % |
| 4 | United Kingdom | 1 | 2.1M $ | 4.04 % |
| 5 | Israel | 1 | 1.1M $ | 2.08 % |
| 6 | Japan | 1 | 689.5K $ | 1.34 % |
| 7 | Canada | 1 | 459.3K $ | 0.89 % |
Cite this page
Titelia. "Holdings of Tema Heart & Health ETF". https://titelia.com/en/funds/S000081541